awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28083872-CA9C3485-236F-41BC-9E3D-198511051852
Q28083872-CA9C3485-236F-41BC-9E3D-198511051852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28083872-CA9C3485-236F-41BC-9E3D-198511051852
Designing biologic selectivity for inflammatory bowel disease--role of vedolizumab
P2860
Q28083872-CA9C3485-236F-41BC-9E3D-198511051852
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28083872-CA9C3485-236F-41BC-9E3D-198511051852
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a93ee85268ca903afe3130e77f8831d734584f72
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.